| Product Code: ETC13337777 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Influenza Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Influenza Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Influenza Vaccines Market - Industry Life Cycle |
3.4 Africa Influenza Vaccines Market - Porter's Five Forces |
3.5 Africa Influenza Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.8 Africa Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Africa Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Africa Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Influenza Vaccines Market Trends |
6 Africa Influenza Vaccines Market, 2021 - 2031 |
6.1 Africa Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Influenza Vaccines Market, Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031 |
6.1.3 Africa Influenza Vaccines Market, Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031 |
6.1.4 Africa Influenza Vaccines Market, Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031 |
6.2 Africa Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Influenza Vaccines Market, Revenues & Volume, By Trivalent Vaccines, 2021 - 2031 |
6.2.3 Africa Influenza Vaccines Market, Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031 |
6.3 Africa Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Influenza Vaccines Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.3.3 Africa Influenza Vaccines Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.3.4 Africa Influenza Vaccines Market, Revenues & Volume, By Geriatric, 2021 - 2031 |
6.4 Africa Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Influenza Vaccines Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.4.3 Africa Influenza Vaccines Market, Revenues & Volume, By Nasal Spray, 2021 - 2031 |
7 Africa Influenza Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
7.3.1 South Africa Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.2 Egypt Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.3 Nigeria Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.4 Rest of Africa Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.4 Africa Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 South Africa Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 Egypt Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 Nigeria Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Rest of Africa Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Africa Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 South Africa Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Egypt Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Nigeria Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Rest of Africa Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8 Africa Influenza Vaccines Market Key Performance Indicators |
9 Africa Influenza Vaccines Market - Export/Import By Countries Assessment |
10 Africa Influenza Vaccines Market - Opportunity Assessment |
10.1 Africa Influenza Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
10.4 Africa Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Africa Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
11 Africa Influenza Vaccines Market - Competitive Landscape |
11.1 Africa Influenza Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Africa Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here